Toth Financial Advisory Corp increased its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 1.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,063 shares of the financial services provider’s stock after buying an additional 564 shares during the quarter. iShares Nasdaq Biotechnology ETF comprises approximately 1.5% of Toth Financial Advisory Corp’s holdings, making the stock its 21st largest position. Toth Financial Advisory Corp owned 0.08% of iShares Nasdaq Biotechnology ETF worth $6,380,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of IBB. Blue Fin Capital Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter worth about $609,000. Allianz Asset Management GmbH lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 340.3% in the 3rd quarter. Allianz Asset Management GmbH now owns 13,210 shares of the financial services provider’s stock worth $1,611,000 after acquiring an additional 10,210 shares during the last quarter. Mutual Advisors LLC lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 29.9% in the 3rd quarter. Mutual Advisors LLC now owns 11,982 shares of the financial services provider’s stock worth $1,461,000 after acquiring an additional 2,755 shares during the last quarter. HRT Financial LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter worth about $2,201,000. Finally, Smith Moore & CO. lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 29.3% in the 3rd quarter. Smith Moore & CO. now owns 5,724 shares of the financial services provider’s stock worth $698,000 after acquiring an additional 1,296 shares during the last quarter. Hedge funds and other institutional investors own 65.97% of the company’s stock.

IBB traded down $0.56 on Monday, reaching $110.49. 2,408,591 shares of the company traded hands, compared to its average volume of 2,289,533. iShares Nasdaq Biotechnology ETF has a one year low of $89.01 and a one year high of $122.97.

ILLEGAL ACTIVITY NOTICE: “Toth Financial Advisory Corp Buys 564 Shares of iShares Nasdaq Biotechnology ETF (IBB)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2019/04/15/toth-financial-advisory-corp-buys-564-shares-of-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: Calculating net profit and net profit margin ratio

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.